All states, territories agree to $7.4B Purdue Pharma opioid settlement
- On June 16, 2025, Purdue Pharma and members of the Sackler family agreed to pay $7.4 billion to settle opioid-related lawsuits brought by 55 U.S. states and territories across the country.
- The settlement follows years of lawsuits claiming OxyContin caused a widespread opioid addiction crisis, with Oklahoma separately settling for $270 million in 2019 and the Supreme Court rejecting an earlier immunity deal in June 2024.
- The agreement compels the Sackler family to relinquish ownership of Purdue Pharma, bars them from engaging in the opioid business, and allocates settlement funds to people affected, as well as to government entities at various levels and Indigenous communities.
- The agreement involves a total payment of approximately $7.4 billion, with the Sackler family contributing around $6.5 billion and Purdue Pharma providing close to $900 million. Disbursements will commence once creditors approve the company’s bankruptcy plan, aiding efforts to combat an opioid epidemic that has caused over 850,000 deaths since 1999.
- Officials called the $7.4 billion deal a major step toward justice and recovery, while noting no amount of money can fully repair the damage caused by decades of aggressive opioid marketing.
89 Articles
89 Articles


Purdue Pharma to pay $7.4 billion in opioid lawsuit settlement
Besides the hefty financial reward, the settlement also ends the Sackler family’s ownership of Purdue Pharma and their ability to sell opioids in the U.S.


55 Attorneys General Sign On to $7.4 Billion Purdue Settlement
Attorney General Hilgers announced on Monday that all 55 attorneys general, representing all eligible states and U.S. territories, agreed to sign on to a $7.4 billion settlement with Purdue Pharma and its owners, the Sackler family.
Virginia agrees to receive up to $103.8 million in opioid crisis settlement with Purdue Pharma, Sackler family
RICHMOND, Va. (WRIC) -- Virginia joined all other states and some U.S. territories in agreeing to sign a $7.4 billion settlement with Purdue Pharma and members of the Sackler family who own the company for their part in creating and perpetuating the opioid crisis. Virginia will receive as much as $103.8 million from this settlement over the next 15 years. According to a release from the Attorney General's Office, that funding will go toward loca…
R.I. to receive nearly $30M in Purdue Pharma opioid settlement
Rhode Island will receive nearly $30 million in a national settlement over Purdue Pharma’s marketing of opioids like OxyContin, a long-acting version of oxycodone first sold in 1995. (Photo by Alexander Castro/Rhode Island Current)Rhode Island will receive nearly $30 million as part of a national $7.4 billion settlement with Purdue Pharma and its owners, the Sackler family, Attorney General Peter Neronha announced Monday. The settlement was supp…
Coverage Details
Bias Distribution
- 72% of the sources are Center
To view factuality data please Upgrade to Premium